Ghrelin agonist does not foster insulin resistance but improves cognition in an Alzheimer’s disease mouse model

The orexigenic hormone ghrelin, a potential antagonist of the insulin system, ensures sufficient serum glucose in times of fasting. In the race for new therapeutics for diabetes, one focus of study has been antagonizing the ghrelin system in order to improve glucose tolerance. We provide evidence fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kunath, Nicolas, van Groen, Thomas, Allison, David B., Kumar, Ashish, Dozier-Sharpe, Monique, Kadish, Inga
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473679/
https://www.ncbi.nlm.nih.gov/pubmed/26090621
http://dx.doi.org/10.1038/srep11452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473679/
https://www.ncbi.nlm.nih.gov/pubmed/26090621
http://dx.doi.org/10.1038/srep11452

Ejemplares similares